期刊文献+

辐射对肝癌细胞HepG2多药耐药基因MDR1表达影响的实验研究 被引量:2

A study on expression of multidrug resistance gene in hepatocular carcinoma cells after irradiation exposure
下载PDF
导出
摘要 目的辐射对肝癌细胞多药耐药性的影响。方法取肝癌细胞株HepG2及HepG2/ADM分别进行X线照射(10Gy),于照射前后分别采用流式细胞仪检测各组细胞表面Pgp变化,采用RT-PCR法检测MDR1表达变化。结果照射前后HepG2细胞表面P-gp阳性表达率分别为:(11.3±1.2)%(、27.4±3.9)%;HepG2/ADM组为:(45.5±5.1)%,(48.1±6.1)%。HepG2组P-gp在细胞膜上的表达较照射前后差异有显著性意义(P<0.01)。结论辐射可诱导肝癌细胞HepG2 mdr1基因表达增强,细胞膜表面Pgp表达增加。对HepG2/ADM耐药性影响较小。 Objective to study the effect on expression rate of muhidrug resistance gene in hepatocular carcinoma cells after irradiation exposure.Methods HepG2 and HepG2/ADM cells were irradiated respectively ( 10 Gy)and the change of Pgp and MDR1 mRNA were detected by flow Cytometry and RT-PCR before and after irradiation respectively.Results The positive rate of Pgp before and after irradiation was( 11.3 ± 1.2) %, (27.4 ± 3.9) % for HepG2 and (45.5 ± 5.1 ) %, (48.1 ± 6.1 )% for HepG2/ADM respectively. There was a significance difference in the HepG2 groups before and after irradiation. Conclusion irradiation can induce overexpression of mdrl gone and Pgp in HepG2 cell line after irradiation exposure, while in HepG2/ADM cell line, the effect has no significance.
出处 《中国实验诊断学》 2006年第1期78-81,共4页 Chinese Journal of Laboratory Diagnosis
基金 辽宁省科技厅自然科学基金资助项目(2001101033)
关键词 肿瘤 肝细胞 多药耐药 carcinoma hepatocellular mutidrug resistance radiochemot herapy
  • 相关文献

参考文献12

  • 1Sturm JW, Keese M. Multimodal treatment of hepatocellular carcinoma(HCC) [J]. Onkologie,2004,27(3) :294.
  • 2Hemming AW,Reed AI, Langham MR Jr,et al. Combined resection of the liver and inferior vena cava for hepatic malignanc[J]. Ann Surg,2004,239(5) :712.
  • 3Jaeck D, Bachellier, P, Oussoultzoglou E, et al. Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term resuits in Europe: an overview [ J ]. Liver Transpl, 2004, 10 ( 2 S1 ) :S58.
  • 4Poon RT, Fan St. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome[ J]. Liver Transpl, 2004, 10 (2S1) :539.
  • 5Zhou XD, Recurrence and metastasis of hepatocellular carcinoma:progress and prospects[J]. Hopatobiliary Pancrcat Dis int, 2002, 1(1):35.
  • 6Grszi G L, Cescon m, Ravaioli M, et al. Liver resection for hepatocellular carcinoma in eirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors forlong - term survival and tumour recurrence in a single centre[J]. Aliment Pharmacol Ther, 2003,17(S2) : 119.
  • 7Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster overy cell matans[J]. Biohim Biophys Acta, 1976,455( 1 ) : 152.
  • 8Hoffmann U, Kroemer HK. The ABC transporters mdr1 and MRP2 :multiple function in disposition of xenobiotics and drug resistance[J]. Drug Metab Rev. 2004,36(3 - 4) :669.
  • 9Mahadevan D, List AF. Targeting the multidrug reslstance-1 transporter in AML: molecular regulation and therapeutic strategies[J].Blood, 2004,104 ( 7 ) : 1940.
  • 10Jamroziak K,Robak T. Pharmacogenomics of mdr1/ABCB1 gene:the influence on risk and clinical outcome of haematological malignancies[ J]. Hematology, 2004,9 (2) : 91.

同被引文献36

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部